# Ibuprofen (Ibuprofen) by Shield Pharmaceuticals Corp: new drug for further processing listing

**Launch Signal Score:** 15/100

| Field | Value |
|---|---|
| Generic name | Ibuprofen |
| NDC | 83059-0184 |
| Labeler | Shield Pharmaceuticals Corp |
| Product type | DRUG FOR FURTHER PROCESSING |
| Approval pathway | DRUG FOR FURTHER PROCESSING |
| Dosage form | TABLET, COATED |
| Active ingredients | IBUPROFEN 200 mg/1 |
| Marketing start | 2026-09-21 |
| Package configurations | 0 |

## Why this score


Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=83059-0184). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.